Influx Healthtech Limited
Influx Healthtech Limited, established in September 2020, specializes in contract manufacturing for B2B clients in nutraceuticals, cosmetics, and more, providing comprehensive services from product formulation to commercialization.
What Influx files
- Others24
- Investor Meet22
- Important10
- Board Meeting6
- Updates5
- PPTs2
Influx Healthtech Limited has announced that its upcoming Annual General Meeting will be held virtually. The company has dispatched weblinks for accessing the annual report to unregistered shareholders and urged physical security holders to complete mandatory KYC updates and dematerialization.
Influx Healthtech reported strong FY26 financials: Revenue surged 40% to ₹146.83 Cr, PAT jumped 54.3% to ₹20.54 Cr. Operational highlights include increased tablet capacity, GMP approval for Tanzania expansion, and launching Olahey Wellness for RTD beverages.
Influx Healthtech Limited has informed the Exchange regarding a press release, titled "Press Release: Financial Result for Half Yearly & Year Ended March 31, 2026".
Influx Healthtech proposes reallocating ₹10.09 Cr from IPO proceeds. Funds from veterinary and machinery will now boost its Nutraceutical CDMO Facility (Plot 59) for a significant scale-up (35,000 to 75,000 sq. ft.), enhancing operational capacity and future revenue.
Influx Healthtech established Olahey Wellness Private Limited, a wholly-owned subsidiary. This new entity, acquired for 0.01 Cr, will focus on pharmaceutical and RTD wellness beverages, signaling business expansion into a new product line.